Furthermore, blocking TrkB with ANA-12 in the NAc shell showed therapeutic effects on depression and behavioral sensitization after repeated METH exposure, confirming the role of the activated BDNF–TrkB signaling pathway in the mechanism of behavioral abnormalities after METH withdrawal. The gene discussed is NTRK2; the disease is major depressive disorder.